Wastewater metaproteomics

tracking microbial and human protein biomarkers

Journal Article (2026)
Author(s)

Claudia G. Tugui (TU Delft - BT/Environmental Biotechnology)

Filine Cordesius (Student TU Delft)

Willem van Holthe (Student TU Delft)

Mark C.M. Van Loosdrecht (TU Delft - BT/Environmental Biotechnology)

Martin Pabst (TU Delft - BT/Environmental Biotechnology)

Research Group
BT/Environmental Biotechnology
DOI related publication
https://doi.org/10.1093/ismeco/ycaf243
More Info
expand_more
Publication Year
2026
Language
English
Research Group
BT/Environmental Biotechnology
Issue number
1
Volume number
6
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Wastewater-based surveillance has become a powerful tool for monitoring the spread of pathogens, antibiotic resistance genes, and measuring population-level exposure to pharmaceuticals and chemicals. While surveillance methods commonly target small molecules, DNA, or RNA, wastewater also contains a vast spectrum of proteins. However, despite recent advances in environmental proteomics, large-scale monitoring of protein biomarkers in wastewater is still far from routine. Analyzing raw wastewater presents a challenge due to its heterogeneous mixture of organic and inorganic substances, microorganisms, cellular debris, and various chemical pollutants. To overcome these obstacles, we developed a wastewater metaproteomics approach including efficient protein extraction and an optimized data-processing pipeline. The pipeline utilizes de novo sequencing to customize large public sequence databases to enable comprehensive metaproteomic coverage. Using this approach, we analyzed wastewater samples collected over approximately three months from two urban locations. This revealed a core microbiome comprising a broad spectrum of microbes, gut bacteria and potential opportunistic pathogens. Additionally, we identified nearly 200 human proteins, including promising population-level health indicators, such as immunoglobulins, uromodulin, and cancer-associated proteins.